… glargine on kidney parameters and outcomes in people with … The kidney composite outcome
was time to first occurrence … , end-stage kidney disease, death owing to kidney failure, or …

… of surgery on kidney outcomes. We were prompted to conduct this study as all previous
randomised controlled trials of metabolic surgery only focused on glycaemic outcomes and not …

… In the pivotal TEMPO 3:4 (Tolvaptan Efficacy and safety in Management of Polycystic kidney
disease and its Outcomes) Clinical Trial, tolvaptan slowed total kidney volume (TKV) growth …

Background Non-nephrotoxic immunosuppressive strategies that allow reduction of
calcineurin-inhibitor exposure without compromising safety or efficacy remain a goal in kidney …

… Studies including prespecified kidney outcome data were identified. Composite kidney
outcomes were reported in a prespecified analysis of the LEADER cardiovascular outcome trial, …

… Donors with HCV generally are young and have few other medical comorbid conditions,
and kidney transplantation outcomes from these donors have been excellent (12). …

… -up of an open-label phase I-II trial of a single infusion of third-party MSC post-kidney
transplantation, in addition to standard immunosuppression. Ten kidney transplant recipients from …

… , respectively), the incidence of new-onset diabetes, and patient and graft outcomes at 2
years. Secondary outcome measures not reported in this article include 5-year graft and patient …

… In this 12-month, multicenter, open-label study, de novo kidney transplant recipients were …
In 123 patients with TAC levels within the protocol-specified range, eGFR outcomes were …

… This was an unmasked, multicentre, prospective, open-label, randomised, controlled trial …
severe acute kidney injury (defined as Kidney Disease: Improving Global Outcomes stage 3) …